Based on a survey of 180 global asset owners, with investment portfolios ranging from US$1 billion to over US$500 billion, the findings highlight a growing focus on alternative investments, ...

Vera Therapeutics completes enrollment in Phase 3 atacicept trial for IgAN, with interim efficacy results expected this ...

Target 2x Long MSTR ETF offers even further leverage on MSTR, and therefore BTC. See why I rate MSTX fund a strong sell.

These eight essential charts reveal why staying invested during market crashes pays off. Learn from 100 years of data how ...

Here's some technical catnip for thodse who like to indulge, courtesy of Mark Newton at Fundstrat. Below is a weekly chart of the S&P 500, with its relative strength index, a momentum gauge, in the ...

Cutting through the confusion is the 2025 AI Index from Stanford University’s Institute for Human-Centered Artificial ...

The valuation tool that's been far more reliable when assessing the priciness of the stock market is the S&P 500's Shiller ...

InvestorPlace CEO Brian Hunt reminded us that free markets, innovation, and productive enterprise have allowed mankind to ...

Johnson & Johnson's Phase 3b APEX study shows Tremfya reduces symptoms and structural damage in psoriatic arthritis patients ...

AI is revolutionizing CrowdStrike Holdings, Inc.'s cybersecurity platform and how it drives shareholder value. Click here to ...

Of the 17 picks we highlighted for 2025, only four are in the black for Q1, with one day left in the quarter. But it’s not a ...

DeFi hacks totaled $22 million in March, while macro-economic worries over Trump’s tariffs saw Bitcoin price slump.